516 related articles for article (PubMed ID: 26514469)
1. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
2. Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes.
Deng L; Zhao X; Chen M; Ji H; Zhang Q; Chen R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):63. PubMed ID: 32393372
[TBL] [Abstract][Full Text] [Related]
3. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Cantarini L; Obici L; Simonini G; Cimaz R; Bacarelli MR; Merlini G; Vitale A; Lucherini OM; Brizi MG; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S108-14. PubMed ID: 22935190
[TBL] [Abstract][Full Text] [Related]
5. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.
Nakajima TE; Yamada Y; Hamano T; Furuta K; Matsuda T; Fujita S; Kato K; Hamaguchi T; Shimada Y
Cancer Sci; 2010 May; 101(5):1286-91. PubMed ID: 20331631
[TBL] [Abstract][Full Text] [Related]
6. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
7. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
Zekri AR; Youssef AS; Lotfy MM; Gabr R; Ahmed OS; Nassar A; Hussein N; Omran D; Medhat E; Eid S; Hussein MM; Ismail MY; Alenzi FQ; Bahnassy AA
PLoS One; 2016; 11(5):e0154130. PubMed ID: 27135244
[TBL] [Abstract][Full Text] [Related]
8. Relations of Serum Visfatin and Resistin Levels with Endometrial Cancer and Factors Associated with its Prognosis.
Ilhan TT; Kebapcilar A; Yilmaz SA; Ilhan T; Kerimoglu OS; Pekin AT; Akyurek F; Unlu A; Celik C
Asian Pac J Cancer Prev; 2015; 16(11):4503-8. PubMed ID: 26107194
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer.
Assiri AM; Kamel HF
Obes Res Clin Pract; 2016; 10(4):442-53. PubMed ID: 26388139
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity.
Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M
Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858
[TBL] [Abstract][Full Text] [Related]
11. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.
Cantarini L; Brucato A; Simonini G; Imazio M; Cumetti D; Cimaz R; Bacarelli MR; Muscari I; Vitale A; Lucherini OM; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2013; 31(2):207-12. PubMed ID: 23137677
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
13. [Serum and synovial adiponectin, resistin, and visfatin levels in rheumatoid arthritis patients. Relation to disease activity].
Alkady EA; Ahmed HM; Tag L; Abdou MA
Z Rheumatol; 2011 Sep; 70(7):602-8. PubMed ID: 21789720
[TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of adiponectin, resistin, and visfatin after mud-bath therapy in patients with bilateral knee osteoarthritis.
Fioravanti A; Giannitti C; Cheleschi S; Simpatico A; Pascarelli NA; Galeazzi M
Int J Biometeorol; 2015 Nov; 59(11):1691-700. PubMed ID: 25750093
[TBL] [Abstract][Full Text] [Related]
17. Significance of Some Non-Invasive Biomarkers in the Early Diagnosis and Staging of Egyptian Breast Cancer Patients.
Motawi TM; Zakhary NI; Darwish HA; Abdullah H; Tadros SA
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3279-3284. PubMed ID: 33247685
[TBL] [Abstract][Full Text] [Related]
18. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
[TBL] [Abstract][Full Text] [Related]
19. Association of plasma visfatin with risk of colorectal cancer: An observational study of Chinese patients.
Chen M; Wang Y; Li Y; Zhao L; Ye S; Wang S; Yu C; Xie H
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e65-74. PubMed ID: 23910020
[TBL] [Abstract][Full Text] [Related]
20. Can adipokines serum levels be used as biomarkers of hand osteoarthritis?
Fioravanti A; Cheleschi S; De Palma A; Addimanda O; Mancarella L; Pignotti E; Pulsatelli L; Galeazzi M; Meliconi R
Biomarkers; 2018 May; 23(3):265-270. PubMed ID: 29105498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]